Prediction of the MammaPrint risk group using MRI features in women with estrogen receptor-positive, HER2-negative, and 1–3 node-positive invasive breast cancer

MRI‐Based Breast Cancer Classification and Localization by Multiparametric Feature Extraction and Combination Using Deep Learning

(2023) Chao Cong et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

(2022) William J. Gradishar et al.   Journal of the National Comprehensive Cancer Network

Validation study of a nomogram for predicting probability of low risk of MammaPrint results in women with clinically high-risk breast cancer

(2022) Young Sol Hwang et al.   Discover Oncology

Association between Oncotype DX recurrence score and dynamic contrast-enhanced MRI features in patients with estrogen receptor-positive HER2-negative invasive breast cancer

(2021) Hee Jeong Kim et al.   CLINICAL IMAGING

Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative

(2021) Paolo Giorgi Rossi et al.   BRITISH JOURNAL OF CANCER

A nomogram for predicting probability of low risk of MammaPrint results in women with clinically high-risk breast cancer

(2021) Young Joo Lee et al.   Scientific Reports

Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scanner

(2020) Giovanna Panzironi et al.   BREAST CANCER RESEARCH AND TREATMENT

MINDACT: Long-term results of the large prospective trial testing the 70-gene signature MammaPrint as guidance for adjuvant chemotherapy in breast cancer patients.

(2020) Fatima Cardoso et al.   JOURNAL OF CLINICAL ONCOLOGY

Association of mammography and ultrasound features with MammaPrint in patients with estrogen receptor-positive, HER2-negative, node-positive invasive breast cancer

(2020) Woo Jung Choi et al.   ACTA RADIOLOGICA

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update—Integration of Results From TAILORx

(2019) Fabrice Andre et al.   JOURNAL OF CLINICAL ONCOLOGY

Invasive Breast Cancer: Prognostic Value of Peritumoral Edema Identified at Preoperative MR Imaging

(2018) Hyejin Cheon et al.   RADIOLOGY

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update

(2017) Ian Krop et al.   JOURNAL OF CLINICAL ONCOLOGY

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

(2016) Fatima Cardoso et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association between Ultrasound Features and the 21-Gene Recurrence Score Assays in Patients with Oestrogen Receptor-Positive, HER2-Negative, Invasive Breast Cancer

(2016) Eun Young Chae et al.   PLoS One

Prediction of Low versus High Recurrence Scores in Estrogen Receptor–Positive, Lymph Node–Negative Invasive Breast Cancer on the Basis of Radiologic-Pathologic Features: Comparison with Oncotype DX Test Recurrence Scores

(2016) Vandana Dialani et al.   RADIOLOGY

MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays

(2016) Hui Li et al.   RADIOLOGY

Pretreatment MR Imaging Features of Triple-Negative Breast Cancer: Association with Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival

(2016) Min Sun Bae et al.   RADIOLOGY

Can mammographic and sonographic imaging features predict the Oncotype DX™ recurrence score in T1 and T2, hormone receptor positive, HER2 negative and axillary lymph node negative breast cancers?

(2014) Monica Maria Yepes et al.   BREAST CANCER RESEARCH AND TREATMENT

Identification of Intrinsic Imaging Phenotypes for Breast Cancer Tumors: Preliminary Associations with Gene Expression Profiles

(2014) Ahmed Bilal Ashraf et al.   RADIOLOGY

An International Ki67 Reproducibility Study

(2013) Mei-Yin C. Polley et al.   JNCI-Journal of the National Cancer Institute

Magnetic Resonance Imaging Features in Triple-Negative Breast Cancer: Comparison With Luminal and HER2-Overexpressing Tumors

(2012) Melania Costantini et al.   Clinical Breast Cancer

Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score

(2011) S Sahebjam et al.   BRITISH JOURNAL OF CANCER

Proliferation (Ki-67 and Phosphohistone H3) and Oncotype DX Recurrence Score in Estrogen Receptor-positive Breast Cancer

(2011) Daron J. Williams et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Sensitivity and Specificity of Unilateral Edema on T2w-TSE Sequences in MR-Mammography Considering 974 Histologically Verified Lesions

(2010) Pascal A. T. Baltzer et al.   Breast Journal

A Lower Allred Score for Progesterone Receptor Is Strongly Associated With a Higher Recurrence Score of 21-Gene Assay in Breast Cancer

(2010) Ping Tang et al.   CANCER INVESTIGATION

Effect of the Enhancement Threshold on the Computer-Aided Detection of Breast Cancer using MRI

(2009) Jacob E.D. Levman et al.   ACADEMIC RADIOLOGY

Computer-aided detection (CAD) for breast MRI: evaluation of efficacy at 3.0 T

(2009) Carla Meeuwis et al.   EUROPEAN RADIOLOGY

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

(2009) Maggie C. U. Cheang et al.   JNCI-Journal of the National Cancer Institute

Triple-Negative Breast Cancer: Correlation between MR Imaging and Pathologic Findings

(2009) Takayoshi Uematsu et al.   RADIOLOGY

Molecular profiles of progesterone receptor loss in human breast tumors

(2008) Chad J. Creighton et al.   BREAST CANCER RESEARCH AND TREATMENT

The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study

(2008) Stella Mook et al.   BREAST CANCER RESEARCH AND TREATMENT